Canopy Growth Q2 FY27 net loss widens to CAD 40.69 million
Bitget2026/11/06 15:08- Canopy Growth's Q2 FY27 net loss widened year-over-year to CAD 40.69 million, primarily due to fair-value charges on Canopy USA-related assets.
- Net revenue rose 22% year-over-year to CAD 81.37 million, while the Cannabis segment posted 30% growth to CAD 66.24 million.
- International markets cannabis net revenue more than doubled to CAD 12.27 million, primarily driven by strong sales in Germany and Poland.
- The Smiths Falls facility received EU GMP certification, expanding the international supply chain, while medical cannabis distribution expanded into the U.K.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
